Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers

Molecular and Cellular Proteomics

Volumn 10, Issue 10, 2011, Pages

  Makawita, Shalini ^a,b   Smith, Chris ^b   Batruch, Ihor ^c   Zheng, Yingye ^d   Rückert, Felix ^e   Grützmann, Robert ^e   Pilarsky, Christian ^e   Gallinger, Steven ^c   Diamandis, Eleftherios P ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d Fred Hutchinson Cancer Research Center   (United States)

^e UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANE PROTEIN; COLLAGEN ALPHA1; OLFACTOMEDIN 4; SECRETORY COMPONENT; SYNCOLLIN; TUMOR MARKER; UNCLASSIFIED DRUG; AGR2 PROTEIN, HUMAN; CARRIER PROTEIN; COLLAGEN TYPE 4; GRANULOCYTE COLONY STIMULATING FACTOR; MEMBRANE PROTEIN; OLFM4 PROTEIN, HUMAN; PROTEIN; PROTEOME; SYCN PROTEIN, RAT;

AREA UNDER THE CURVE; ARTICLE; BODY FLUID; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; ION EXCHANGE CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS JUICE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SEQUENCE HOMOLOGY; TISSUE SPECIFICITY; BLOOD; CHEMISTRY; CULTURE MEDIUM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PANCREAS CARCINOMA; PANCREAS TUMOR; TUMOR CELL LINE;

CARCINOMA, PANCREATIC DUCTAL; CARRIER PROTEINS; CELL LINE, TUMOR; COLLAGEN TYPE IV; CULTURE MEDIA, CONDITIONED; GENE EXPRESSION REGULATION, NEOPLASTIC; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MEMBRANE PROTEINS; PANCREATIC JUICE; PANCREATIC NEOPLASMS; PROTEINS; PROTEOME; RECEPTORS, POLYMERIC IMMUNOGLOBULIN; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 80054044048     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.008599     Document Type: Article

References (124)

1. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., and Thun, M. J. (2009) Cancer statistics, 2009. CA Cancer J. Clin. 59, 225-249
2. Maitra, A., and Hruban, R. H. (2008) Pancreatic cancer. Annu. Rev. Pathol. 3, 157-188 (Pubitemid 351488279)
3. Goonetilleke, K. S., and Siriwardena, A. K. (2007) Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur. J. Surg. Oncol. 33, 266-270 (Pubitemid 46488663)
4. Magnani, J. L., Steplewski, Z., Koprowski, H., and Ginsburg, V. (1983) Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. Cancer Res. 43, 5489-5492 (Pubitemid 14230170)
5. Marrelli, D., Caruso, S., Pedrazzani, C., Neri, A., Fernandes, E., Marini, M., Pinto, E., and Roviello, F. (2009) CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions. Am. J. Surg. 198, 333-339
6. Nazli, O., Bozdag, A. D., Tansug, T., Kir, R., and Kaymak, E. (2000) The diagnostic importance of CEA and CA 19-9 for the early diagnosis of pancreatic carcinoma. Hepatogastroenterology 47, 1750-1752
7. Tsavaris, N., Kosmas, C., Papadoniou, N., Kopteridis, P., Tsigritis, K., Dokou, A., Sarantonis, J., Skopelitis, H., Tzivras, M., Gennatas, K., Polyzos, A., Papastratis, G., Karatzas, G., and Papalambros, A. (2009) CEA and CA-19.9 serum tumor markers as prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis. J. Chemother. 21, 673-680
8. Gold, D. V., Modrak, D. E., Ying, Z., Cardillo, T. M., Sharkey, R. M., and Goldenberg, D. M. (2006) New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis. J. Clin. Oncol. 24, 252-258 (Pubitemid 46622054)
9. Ringel, J., and Löhr, M. (2003) The MUC gene family: their role in diagnosis and early detection of pancreatic cancer. Mol. Cancer 2, 9
10. Rückert, F., Pilarsky, C., and Grützmann, R. (2010) Serum tumor markers in pancreatic cancer-recent discoveries. Cancers 2, 1107-1124
11. Robin, X., Turck, N., Hainard, A., Lisacek, F., Sanchez, J. C., and Müller, M. (2009) Bioinformatics for protein biomarker panel classification: what is needed to bring biomarker panels into in vitro diagnostics? Expert Rev. Proteomics 6, 675-689
12. Tanase, C. P., Neagu, M., Albulescu, R., and Hinescu, M. E. (2010) Advances in pancreatic cancer detection. Adv. Clin. Chem. 51, 145-180
13. Yurkovetsky, Z. R., Linkov, F. Y., D, E. M., and Lokshin, A. E. (2006) Multiple biomarker panels for early detection of ovarian cancer. Future Oncol. 2,733-741 (Pubitemid 44941991)
14. Kulasingam, V., and Diamandis, E. P. (2008) Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nat. Clin. Pract. Oncol. 5, 588-599
15. Hanash, S., and Taguchi, A. (2010) The grand challenge to decipher the cancer proteome. Nat. Rev. Cancer 10, 652-660
16. Kulasingam, V., Pavlou, M. P., and Diamandis, E. P. (2010) Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer. Nat. Rev cancer 10, 371-378
17. Rifai, N., Gillette, M. A., and Carr, S. A. (2006) Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol. 24, 971-983 (Pubitemid 44215392)
18. Sedlaczek, P., Frydecka, I., Gabryś, M., Van Dalen, A., Einarsson, R., and Harlozińska, A. (2002) Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma. Cancer 95, 1886-1893 (Pubitemid 35222168)
19. Chen, R., Pan, S., Cooke, K., Moyes, K. W., Bronner, M. P., Goodlett, D. R., Aebersold, R., and Brentnall, T. A. (2007) Comparison of pancreas juice proteins from cancer versus pancreatitis using quantitative proteomic analysis. Pancreas 34, 70-79 (Pubitemid 46045723)
20. Chen, R., Pan, S., Yi, E. C., Donohoe, S., Bronner, M. P., Potter, J. D., Goodlett, D. R., Aebersold, R., and Brentnall, T. A. (2006) Quantitative proteomic profiling of pancreatic cancer juice. Proteomics 6, 3871-3879 (Pubitemid 44065164)
21. Farina, A., Dumonceau, J. M., Frossard, J. L., Hadengue, A., Hochstrasser, D. F., and Lescuyer, P. (2009) Proteomic analysis of human bile from malignant biliary stenosis induced by pancreatic cancer. J. Proteome Res. 8, 159-169
22. Grønborg, M., Bunkenborg, J., Kristiansen, T. Z., Jensen, O. N., Yeo, C. J., Hruban, R. H., Maitra, A., Goggins, M. G., and Pandey, A. (2004) Comprehensive proteomic analysis of human pancreatic juice. J. Proteome Res. 3, 1042-1055 (Pubitemid 39425662)
23. Ke, E., Patel, B. B., Liu, T., Li, X. M., Haluszka, O., Hoffman, J. P., Ehya, H., Young, N. A., Watson, J. C., Weinberg, D. S., Nguyen, M. T., Cohen, S. J., Meropol, N. J., Litwin, S., Tokar, J. L., and Yeung, A. T. (2009) Proteomic analyses of pancreatic cyst fluids. Pancreas 38, e33-42
24. Rosty, C., Christa, L., Kuzdzal, S., Baldwin, W. M., Zahurak, M. L., Carnot, F., Chan, D. W., Canto, M., Lillemoe, K. D., Cameron, J. L., Yeo, C. J., Hruban, R. H., and Goggins, M. (2002) Identification of hepatocarcinoma- intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res. 62, 1868-1875 (Pubitemid 34408515)
25. Tian, M., Cui, Y. Z., Song, G. H., Zong, M. J., Zhou, X. Y., Chen, Y., and Han, J. X. (2008) Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients. BMC Cancer 8, 241
26. Zhou, L., Lu, Z., Yang, A., Deng, R., Mai, C., Sang, X., Faber, K. N., and Lu, X. (2007) Comparative proteomic analysis of human pancreatic juice: methodological study. Proteomics 7, 1345-1355 (Pubitemid 46716055)
27. Gunawardana, C. G., Kuk, C., Smith, C. R., Batruch, I., Soosaipillai, A., and Diamandis, E. P. (2009) Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer. J. Proteome Res. 8, 4705-4713
28. Kulasingam, V., and Diamandis, E. P. (2007) Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets. Mol. Cell Proteomics 6, 1997-2011 (Pubitemid 350201873)
29. Planque, C., Kulasingam, V., Smith, C. R., Reckamp, K., Goodglick, L., and Diamandis, E. P. (2009) Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines. Mol. Cell Proteomics 8, 2746-2758
30. Sardana, G., Jung, K., Stephan, C., and Diamandis, E. P. (2008) Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers. J. Proteome Res. 7, 3329-3338
31. Feng, X. P., Yi, H., Li, M. Y., Li, X. H., Yi, B., Zhang, P. F., Li, C., Peng, F., Tang, C. E., Li, J. L., Chen, Z. C., and Xiao, Z. Q. (2010) Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics. Cancer Res. 70, 3450-3462
32. Wu, C. C., Hsu, C. W., Chen, C. D., Yu, C. J., Chang, K. P., Tai, D. I., Liu, H. P., Su, W. H., Chang, Y. S., and Yu, J. S. (2010) Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas. Mol. Cell Proteomics 9, 1100-1117
33. Xue, H., Lü, B., Zhang, J., Wu, M., Huang, Q., Wu, Q., Sheng, H., Wu, D., Hu, J., and Lai, M. (2010) Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach. J. Proteome Res. 9, 545-555
34. Grønborg, M., Kristiansen, T. Z., Iwahori, A., Chang, R., Reddy, R., Sato, N., Molina, H., Jensen, O. N., Hruban, R. H., Goggins, M. G., Maitra, A., and Pandey, A. (2006) Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol. Cell Proteomics 5, 157-171 (Pubitemid 43169348)
35. Mauri, P., Scarpa, A., Nascimbeni, A. C., Benazzi, L., Parmagnani, E., Mafficini, A., Della Peruta, M., Bassi, C., Miyazaki, K., and Sorio, C. (2005) Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers. FASEB J. 19, 1125-1127 (Pubitemid 40946439)
36. Schiarea, S., Solinas, G., Allavena, P., Scigliuolo, G. M., Bagnati, R., Fanelli, R., and Chiabrando, C. (2010) Secretome analysis of multiple pancreatic cancer cell lines reveals perturbations of key functional networks. J. Proteome Res. 9, 4376-4392
37. Kulasingam, V., and Diamandis, E. P. (2008) Tissue culture-based breast cancer biomarker discovery platform. Int. J. Cancer 123, 2007-2012
38. Björling, E., Lindskog, C., Oksvold, P., Linné, J., Kampf, C., Hober, S., Uhlén, M., and Ponten, F. (2008) A web-based tool for in silico biomarker discovery based on tissue-specific protein profiles in normal and cancer tissues. Mol. Cell Proteomics 7, 825-844 (Pubitemid 351737085)
39. Xiao, S. J., Zhang, C., Zou, Q., and Ji, Z. L. (2010) TiSGeD: a database for tissue-specific genes. Bioinformatics 26, 1273-1275
40. Liu, X., Yu, X., Zack, D. J., Zhu, H., and Qian, J. (2008) TiGER: a database for tissue-specific gene expression and regulation. BMC Bioinformatics 9, 271
41. Pontius J. U., Wagner L., and Schuler G. D. (2003) UniGene: a unified view of the transcriptome. The NCBI Handbook, pp. 21.21-21.12, National Center for Biotechnology Information, Bathesda, MD.
42. Pontén, F., Jirström, K., and Uhlen, M. (2008) The Human Protein Atlas-a tool for pathology. J. Pathol. 216, 387-393
43. Deer, E. L., González-Hernández, J., Coursen, J. D., Shea, J. E., Ngatia, J., Scaife, C. L., Firpo, M. A., and Mulvihill, S. J. (2010) Phenotype and genotype of pancreatic cancer cell lines. Pancreas 39, 425-435
44. Sipos, B., Möser, S., Kalthoff, H., Török, V., Löhr, M., and Klöppel, G. (2003) A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform. Virchows Arch. 442, 444-452 (Pubitemid 36718311)
45. Furukawa, T., Duguid, W. P., Rosenberg, L., Viallet, J., Galloway, D. A., and Tsao, M. S. (1996) Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16. Am. J. Pathol. 148, 1763-1770 (Pubitemid 26171674)
46. Sedmak, J. J., and Grossberg, S. E. (1977) A rapid, sensitive, and versatile assay for protein using Coomassie brilliant blue G250. Analyt. Biochem. 79, 544-552 (Pubitemid 8105123)
47. Itzhaki, R. F., and Gill, D. M. (1964) A Micro-Biuret Method for Estimating Proteins. Analyt. Biochem. 9, 401-410
48. Caraux, G., and Pinloche, S. (2005) PermutMatrix: a graphical environment to arrange gene expression profiles in optimal linear order. Bioinformatics 21, 1280-1281 (Pubitemid 40467961)
49. Meunier, B., Dumas, E., Piec, I., Béchet, D., Hébraud, M., and Hocquette, J. F. (2007) Assessment of hierarchical clustering methodologies for proteomic data mining. J. Proteome Res. 6, 358-366 (Pubitemid 46173687)
50. Bachi, A., and Bonaldi, T. (2008) Quantitative proteomics as a new piece of the systems biology puzzle. J. Proteomics 71, 357-367
51. Liu, H., Sadygov, R. G., and Yates, J. R., 3rd (2004) A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 76, 4193-4201 (Pubitemid 38943698)
52. Zhu, W., Smith, J. W., and Huang, C. M. Mass spectrometry-based label-free quantitative proteomics. J. Biomed. Biotechnol. 2010: 840518, 2010
53. Luo, L. Y., Soosaipillai, A., Grass, L., and Diamandis, E. P. (2006) Characterization of human kallikreins 6 and 10 in ascites fluid from ovarian cancer patients. Tumour Biol. 27, 227-234 (Pubitemid 44260247)
54. Shaw, J. L., and Diamandis, E. P. (2007) Distribution of 15 human kallikreins in tissues and biological fluids. Clin. Chem. 53, 1423-1432 (Pubitemid 47206338)
55. Choi, H., and Nesvizhskii, A. I. (2008) False discovery rates and related statistical concepts in mass spectrometry-based proteomics. J. Proteome Res. 7, 47-50 (Pubitemid 351171114)
56. Elias, J. E., and Gygi, S. P. (2007) Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 4, 207-214 (Pubitemid 46358868)
57. Higdon, R., Hogan, J. M., Van Belle, G., and Kolker, E. (2005) Randomized sequence databases for tandem mass spectrometry peptide and protein identification. Omics 9, 364-379 (Pubitemid 43235291)
58. Kanehisa, M., and Goto, S. (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucl. Acids Res. 28, 27-30 (Pubitemid 30047706)
59. Kanehisa, M., Goto, S., Furumichi, M., Tanabe, M., and Hirakawa, M. (2010) KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucl. Acids Res. 38, D355-360
60. Reddi, K. K., and Holland, J. F. (1976) Elevated serum ribonuclease in patients with pancreatic cancer. Proc. Natl. Acad. Sci. U. S. A. 73, 2308-2310
61. Harsha, H. C., Kandasamy, K., Ranganathan, P., Rani, S., Ramabadran, S., Gollapudi, S., Balakrishnan, L., Dwivedi, S. B., Telikicherla, D., Selvan, L. D., Goel, R., Mathivanan, S., Marimuthu, A., Kashyap, M., Vizza, R. F., Mayer, R. J., Decaprio, J. A., Srivastava, S., Hanash, S. M., Hruban, R. H., and Pandey, A. (2009) A compendium of potential biomarkers of pancreatic cancer. PLoS Med. 6, e1000046
62. Chen, R., Pan, S., Duan, X., Nelson, B. H., Sahota, R. A., de Rham, S., Kozarek, R. A., McIntosh, M., and Brentnall, T. A. (2010) Elevated level of anterior gradient-2 in pancreatic juice from patients with premalignant pancreatic neoplasia. Mol. Cancer 9, 149
63. Hanas, J. S., Hocker, J. R., Cheung, J. Y., Larabee, J. L., Lerner, M. R., Lightfoot, S. A., Morgan, D. L., Denson, K. D., Prejeant, K. C., Gusev, Y., Smith, B. J., Hanas, R. J., Postier, R. G., and Brackett, D. J. (2008) Biomarker identification in human pancreatic cancer sera. Pancreas 36, 61-69
64. Irigoyen Oyarzabal, A. M., Amiguet Garcia, J. A., López Vivanco, G., Genollá Subirats, J., Muñoz Villafranca, M. C., Ojembarrena Martínez, E., and Liso Irurzun, P. (2003) [Tumoral markers and acute-phase reactants in the diagnosis of pancreatic cancer]. Gastroenterol. Hepatol. 26, 624-629
65. Itkonen, O., Koivunen, E., Hurme, M., Alfthan, H., Schröder, T., and Stenman, U. H. (1990) Time-resolved immunofluorometric assays for trypsinogen-1 and 2 in serum reveal preferential elevation of trypsinogen-2 in pancreatitis. J. Lab. Clin. Med. 115, 712-718 (Pubitemid 20213162)
66. Koopmann, J., Buckhaults, P., Brown, D. A., Zahurak, M. L., Sato, N., Fukushima, N., Sokoll, L. J., Chan, D. W., Yeo, C. J., Hruban, R. H., Breit, S. N., Kinzler, K. W., Vogelstein, B., and Goggins, M. (2004) Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers. Clin. Cancer Res. 10, 2386-2392 (Pubitemid 38445697)
67. Koopmann, J., Rosenzweig, C. N., Zhang, Z., Canto, M. I., Brown, D. A., Hunter, M., Yeo, C., Chan, D. W., Breit, S. N., and Goggins, M. (2006) Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9. Clin. Cancer Res. 12, 442-446 (Pubitemid 43166133)
68. Kuhlmann, K. F., van Till, J. W., Boermeester, M. A., de Reuver, P. R., Tzvetanova, I. D., Offerhaus, G. J., Ten Kate, F. J., Busch, O. R., van Gulik, T. M., Gouma, D. J., and Crawford, H. C. (2007) Evaluation of matrix metalloproteinase 7 in plasma and pancreatic juice as a biomarker for pancreatic cancer. Cancer Epidemiol. Biomarkers Prev. 16, 886-891 (Pubitemid 46910086)
69. Maker, A. V., Katabi, N., Gonen, M., DeMatteo, R. P., D'Angelica, M. I., Fong, Y., Jarnagin, W. R., Brennan, M. F., and Allen, P. J. (2011) Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas. Ann. Surg. Oncol. 18, 199-206
70. Märten, A., Bächler, M. W., Werft, W., Wente, M. N., Kirschfink, M., and Schmidt, J. (2010) Soluble iC3b as an early marker for pancreatic adenocarcinoma is superior to CA19.9 and radiology. J. Immunother. 33, 219-224
71. Moniaux, N., Chakraborty, S., Yalniz, M., Gonzalez, J., Shostrom, V. K., Standop, J., Lele, S. M., Ouellette, M., Pour, P. M., Sasson, A. R., Brand, R. E., Hollingsworth, M. A., Jain, M., and Batra, S. K. (2008) Early diagnosis of pancreatic cancer: neutrophil gelatinaseassociated lipocalin as a marker of pancreatic intraepithelial neoplasia. Br. J. Cancer 98, 1540-1547 (Pubitemid 351652327)
72. Saha, S., Harrison, S. H., Shen, C., Tang, H., Radivojac, P., Arnold, R. J., Zhang, X., and Chen, J. Y. (2008) HIP2: an online database of human plasma proteins from healthy individuals. BMC Med. Genomics 1, 12
73. Jones, S., Zhang, X., Parsons, D. W., Lin, J. C., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., Hong, S. M., Fu, B., Lin, M. T., Calhoun, E. S., Kamiyama, M., Walter, K., Nikolskaya, T., Nikolsky, Y., Hartigan, J., Smith, D. R., Hidalgo, M., Leach, S. D., Klein, A. P., Jaffee, E. M., Goggins, M., Maitra, A., Iacobuzio-Donahue, C., Eshleman, J. R., Kern, S. E., Hruban, R. H., Karchin, R., Papadopoulos, N., Parmigiani, G., Vogelstein, B., Velculescu, V. E., and Kinzler, K. W. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321, 1801-1806
74. Adrian, T. E., Besterman, H. S., Mallinson, C. N., Pera, A., Redshaw, M. R., Wood, T. P., and Bloom, S. R. (1979) Plasma trypsin in chronic pancreatitis and pancreatic adenocarcinoma. Clin. Chim. Acta 97, 205-212 (Pubitemid 10241621)
75. Artigas, J. M., Garcia, M. E., Faure, M. R., and Gimeno, A. M. (1981) Serum trypsin levels in acute pancreatic and non-pancreatic abdominal conditions. Postgrad. Med. J. 57, 219-222 (Pubitemid 11096928)
76. Borgström, A., and Regnér, S. (2005) Active carboxypeptidase B is present in free form in serum from patients with acute pancreatitis. Pancreatology 5, 530-536
77. Funakoshi, A., Yamada, Y., Ito, T., Ishikawa, H., Yokota, M., Shinozaki, H., Wakasugi, H., Misaki, A., and Kono, M. (1991) Clinical usefulness of serum phospholipase A2 determination in patients with pancreatic diseases. Pancreas 6, 588-594
78. Hao, Y., Wang, J., Feng, N., and Lowe, A. W. (2004) Determination of plasma glycoprotein 2 levels in patients with pancreatic disease. Arch. Pathol. Lab. Med. 128, 668-674 (Pubitemid 41490428)
79. Hayakawa, T., Kondo, T., Shibata, T., Kitagawa, M., Ono, H., Sakai, Y., and Kiriyama, S. (1989) Enzyme immunoassay for serum pancreatic lipase in the diagnosis of pancreatic diseases. Gastroenterol. Jpn. 24, 556-560 (Pubitemid 19276764)
80. Hayakawa, T., Kondo, T., Shibata, T., Kitagawa, M., Sakai, Y., Sobajima, H., Tanikawa, M., Nakae, Y., Hayakawa, S., Katsuzaki, T., et al. (1993) Serum pancreatic stone protein in pancreatic diseases. Int. J. Pancreatol. 13, 97-103 (Pubitemid 23118449)
81. Junge, W., and Leybold, K. (1982) Detection of colipase in serum and urine of pancreatitis patients. Clin. Chim. Acta 123, 293-302 (Pubitemid 12098584)
82. Matsugi, S., Hamada, T., Shioi, N., Tanaka, T., Kumada, T., and Satomura, S. (2007) Serum carboxypeptidase A activity as a biomarker for early-stage pancreatic carcinoma. Clin. Chim. Acta 378, 147-153 (Pubitemid 46242208)
83. Pasanen, P. A., Eskelinen, M., Partanen, K., Pikkarainen, P., Penttilä, I., and Alhava, E. (1994) Tumour-associated trypsin inhibitor in the diagnosis of pancreatic carcinoma. J. Cancer Res. Clin. Oncol. 120, 494-497 (Pubitemid 24205127)
84. Smith, R. C., Southwell-Keely, J., and Chesher, D. (2005) Should serum pancreatic lipase replace serum amylase as a biomarker of acute pancreatitis? ANZ J. Surg. 75, 399-404 (Pubitemid 40896900)
85. Wistuba, II, Behrens, C., Milchgrub, S., Syed, S., Ahmadian, M., Virmani, A. K., Kurvari, V., Cunningham, T. H., Ashfaq, R., Minna, J. D., and Gazdar, A. F. (1998) Comparison of features of human breast cancer cell lines and their corresponding tumors. Clin. Cancer Res. 4, 2931-2938 (Pubitemid 29001464)
86. Wistuba, II, Bryant, D., Behrens, C., Milchgrub, S., Virmani, A. K., Ashfaq, R., Minna, J. D., and Gazdar, A. F. (1999) Comparison of features of human lung cancer cell lines and their corresponding tumors. Clin. Cancer Res. 5, 991-1000 (Pubitemid 29233212)
87. Sobel, R. E., and Sadar, M. D. (2005) Cell lines used in prostate cancer research: a compendium of old and new lines-part 1. J. Urol. 173, 342-359
88. Domon, B., and Aebersold, R. (2006) Challenges and opportunities in proteomics data analysis. Mol. Cell Proteomics 5, 1921-1926 (Pubitemid 44688200)
89. Kapp, E. A., Schütz, F., Connolly, L. M., Chakel, J. A., Meza, J. E., Miller, C. A., Fenyo, D., Eng, J. K., Adkins, J. N., Omenn, G. S., and Simpson, R. J. (2005) An evaluation, comparison, and accurate benchmarking of several publicly available MS/MS search algorithms: sensitivity and specificity analysis. Proteomics 5, 3475-3490 (Pubitemid 41192052)
90. Barnea, E., Sorkin, R., Ziv, T., Beer, I., and Admon, A. (2005) Evaluation of prefractionation methods as a preparatory step for multidimensional based chromatography of serum proteins. Proteomics 5, 3367-3375 (Pubitemid 41192042)
91. Das, S., Bosley, A. D., Ye, X., Chan, K. C., Chu, I., Green, J. E., Issaq, H. J., Veenstra, T. D., and Andresson, T. (2010) Comparison of Strong Cation Exchange and SDS-PAGE Fractionation for Analysis of Multiprotein Complexes. J. Proteome Res. 9, 6696-6704
92. Fang, Y., Robinson, D. P., and Foster, L. J. (2010) Quantitative analysis of proteome coverage and recovery rates for upstream fractionation methods in proteomics. J. Proteome Res. 9, 1902-1912
93. Slebos, R. J., Brock, J. W., Winters, N. F., Stuart, S. R., Martinez, M. A., Li, M., Chambers, M. C., Zimmerman, L. J., Ham, A. J., Tabb, D. L., and Liebler, D. C. (2008) Evaluation of strong cation exchange versus isoelectric focusing of peptides for multidimensional liquid chromatography-tandem mass spectrometry. J. Proteome Res. 7, 5286-5294
94. Ishihama, Y., Oda, Y., Tabata, T., Sato, T., Nagasu, T., Rappsilber, J., and Mann, M. (2005) Exponentially modified protein abundance index (em-PAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol. Cell Proteomics 4, 1265-1272 (Pubitemid 41448714)
95. Lu, P., Vogel, C., Wang, R., Yao, X., and Marcotte, E. M. (2007) Absolute protein expression profiling estimates the relative contributions of transcriptional and translational regulation. Nat. Biotechnol. 25, 117-124 (Pubitemid 46087910)
96. Collier, T. S., Sarkar, P., Franck, W. L., Rao, B. M., Dean, R. A., and Muddiman, D. C. (2010) Direct Comparison of Stable Isotope Labeling by Amino Acids in Cell Culture and Spectral Counting for Quantitative Proteomics. Anal. Chem. 82, 8696-8702
97. Kakisaka, T., Kondo, T., Okano, T., Fujii, K., Honda, K., Endo, M., Tsuchida, A., Aoki, T., Itoi, T., Moriyasu, F., Yamada, T., Kato, H., Nishimura, T., Todo, S., and Hirohashi, S. (2007) Plasma proteomics of pancreatic cancer patients by multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis (2D-DIGE): up-regulation of leucine-rich alpha-2-glycoprotein in pancreatic cancer. J. Chromatogr. B 852, 257-267 (Pubitemid 46830120)
98. Inami, K., Kajino, K., Abe, M., Hagiwara, Y., Maeda, M., Suyama, M., Watanabe, S., and Hino, O. (2008) Secretion of N-ERC/mesothelin and expression of C-ERC/mesothelin in human pancreatic ductal carcinoma. Oncol. Rep. 20, 1375-1380
99. Paciucci, R., Torà, M., Diaz, V. M., and Real, F. X. (1998) The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro. Oncogene 16, 625-633 (Pubitemid 28062342)
100. Frick, V. O., Rubie, C., Wagner, M., Graeber, S., Grimm, H., Kopp, B., Rau, B. M., and Schilling, M. K. (2008) Enhanced ENA-78 and IL-8 expression in patients with malignant pancreatic diseases. Pancreatology 8, 488-497
101. Rückert, F., Joensson, P., Saeger, H. D., Grützmann, R., and Pilarsky, C. (2010) Functional analysis of LOXL2 in pancreatic carcinoma. Int. J. Colorectal Dis. 25, 303-311
102. Aberger, F., Weidinger, G., Grunz, H., and Richter, K. (1998) Anterior specification of embryonic ectoderm: the role of the Xenopus cement gland-specific gene XAG-2. Mech. Dev. 72, 115-130 (Pubitemid 28186711)
103. Barraclough, D. L., Platt-Higgins, A., de Silva Rudland, S., Barraclough, R., Winstanley, J., West, C. R., and Rudland, P. S. (2009) The metastasis-associated anterior gradient 2 protein is correlated with poor survival of breast cancer patients. Am. J. Pathol. 175, 1848-1857
104. Fritzsche, F. R., Dahl, E., Dankof, A., Burkhardt, M., Pahl, S., Petersen, I., Dietel, M., and Kristiansen, G. (2007) Expression of AGR2 in non small cell lung cancer. Histol. Histopathol. 22, 703-708 (Pubitemid 47034136)
105. Zhang, Y., Forootan, S. S., Liu, D., Barraclough, R., Foster, C. S., Rudland, P. S., and Ke, Y. (2007) Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patients. Prostate Cancer Prostatic Dis. 10, 293-300 (Pubitemid 47351409)
106. Ramachandran, V., Arumugam, T., Wang, H., and Logsdon, C. D. (2008) Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival. Cancer Res. 68, 7811-7818
107. Zhang, Y., Ali, T. Z., Zhou, H., D'Souza, D. R., Lu, Y., Jaffe, J., Liu, Z., Passaniti, A., and Hamburger, A. W. (2010) ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer. Cancer Res. 70, 240-248
108. DeSouza, L. V., Romaschin, A. D., Colgan, T. J., and Siu, K. W. (2009) Absolute quantification of potential cancer markers in clinical tissue homogenates using multiple reaction monitoring on a hybrid triple quadrupole/linear ion trap tandem mass spectrometer. Anal. Chem. 81, 3462-3470
109. Hessle, H., and Engvall, E. (1984) Type VI collagen. Studies on its localization, structure, and biosynthetic form with monoclonal antibodies. J. Biol. Chem. 259, 3955-3961 (Pubitemid 14170112)
110. Fujita, A., Sato, J. R., Festa, F., Gomes, L. R., Oba-Shinjo, S. M., Marie, S. K., Ferreira, C. E., and Sogayar, M. C. (2008) Identification of COL6A1 as a differentially expressed gene in human astrocytomas. Genet. Mol. Res. 7, 371-378
111. Rovira, M., Delaspre, F., Massumi, M., Serra, S. A., Valverde, M. A., Lloreta, J., Dufresne, M., Payre, B., Konieczny, S. F., Savatier, P., Real, F. X., and Skoudy, A. (2008) Murine embryonic stem cell-derived pancreatic acinar cells recapitulate features of early pancreatic differentiation. Gastroenterology 135, 1301-1310, 1310. e1-5
112. Li, J., Dowdy, S., Tipton, T., Podratz, K., Lu, W. G., Xie, X., and Jiang, S. W. (2009) HE4 as a biomarker for ovarian and endometrial cancer management. Expert Rev. Mol. Diagn. 9, 555-566
113. Welsh, J. B., Sapinoso, L. M., Kern, S. G., Brown, D. A., Liu, T., Bauskin, A. R., Ward, R. L., Hawkins, N. J., Quinn, D. I., Russell, P. J., Sutherland, R. L., Breit, S. N., Moskaluk, C. A., Frierson, H. F., Jr., and Hampton, G. M. (2003) Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc. Natl. Acad. Sci. U. S. A. 100, 3410-3415 (Pubitemid 36356597)
114. Grapin-Botton, A. (2005) Ductal cells of the pancreas. Int. J. Biochem. Cell Biol. 37, 504-510
115. Rovira, M., Delaspre, F., Massumi, M., Serra, S. A., Valverde, M. A., Lloreta, J., Dufresne, M., Payre, B., Konieczny, S. F., Savatier, P., Real, F. X., and Skoudy, A. (2008) Murine embryonic stem cell-derived pancreatic acinar cells recapitulate features of early pancreatic differentiation. Gastroenterology 135, 1301-1310, e1-5
116. Schmid, R. M. (2002) Acinar-to-ductal metaplasia in pancreatic cancer development. J. Clin. Invest. 109, 1403-1404
117. Schmid, R. M., Klöppel, G., Adler, G., and Wagner, M. (1999) Acinarductal-carcinoma sequence in transforming growth factor-alpha transgenic mice. Ann. N Y Acad. Sci. 880, 219-230 (Pubitemid 29349130)
118. Kobayashi, D., Koshida, S., Moriai, R., Tsuji, N., and Watanabe, N. (2007) Olfactomedin 4 promotes S-phase transition in proliferation of pancreatic cancer cells. Cancer Sci. 98, 334-340 (Pubitemid 46195603)
119. Oue, N., Sentani, K., Noguchi, T., Ohara, S., Sakamoto, N., Hayashi, T., Anami, K., Motoshita, J., Ito, M., Tanaka, S., Yoshida, K., and Yasui, W. (2009) Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients. Int. J. Cancer 125, 2383-2392
120. Antonin, W., Wagner, M., Riedel, D., Brose, N., and Jahn, R. (2002) Loss of the zymogen granule protein syncollin affects pancreatic protein synthesis and transport but not secretion. Mol. Cell. Biol. 22, 1545-1554 (Pubitemid 34150790)
121. Faca, V. M., Song, K. S., Wang, H., Zhang, Q., Krasnoselsky, A. L., Newcomb, L. F., Plentz, R. R., Gurumurthy, S., Redston, M. S., Pitteri, S. J., Pereira-Faca, S. R., Ireton, R. C., Katayama, H., Glukhova, V., Phanstiel, D., Brenner, D. E., Anderson, M. A., Misek, D., Scholler, N., Urban, N. D., Barnett, M. J., Edelstein, C., Goodman, G. E., Thornquist, M. D., McIntosh, M. W., DePinho, R. A., Bardeesy, N., and Hanash, S. M. (2008) A mouse to human search for plasma proteome changes associated with pancreatic tumor development. PLoS Med. 5, e123
122. Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., Velculescu, V. E., Kinzler, K. W., Vogelstein, B., and Iacobuzio-Donahue, C. A. (2010) Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114-1117
123. Mischak, H., Allmaier, G., Apweiler, R., Attwood, T., Baumann, M., Benigni, A., Bennett, S. E., Bischoff, R., Bongcam-Rudloff, E., Capasso, G., Coon, J. J., D'Haese, P., Dominiczak, A. F., Dakna, M., Dihazi, H., Ehrich, J. H., Fernandez-Llama, P., Fliser, D., Frokiaer, J., Garin, J., Girolami, M., Hancock, W. S., Haubitz, M., Hochstrasser, D., Holman, R. R., Ioannidis, J. P., Jankowski, J., Julian, B. A., Klein, J. B., Kolch, W., Luider, T., Massy, Z., Mattes, W. B., Molina, F., Monsarrat, B., Novak, J., Peter, K., Rossing, P., Sánchez-Carbayo, M., Schanstra, J. P., Semmes, O. J., Spasovski, G., Theodorescu, D., Thongboonkerd, V., Vanholder, R., Veenstra, T. D., Weissinger, E., Yamamoto, T., and Vlahou, A. (2010) Recommendations for biomarker identification and qualification in clinical proteomics. Sci. Transl. Med. 2, 46ps42
124. Cutts, R. J., Gadaleta, E., Hahn, S. A., Crnogorac-Jurcevic, T., Lemoine, N. R., and Chelala, C. (2010) The Pancreatic Expression database: 2011 update. Nucleic Acids Res. 39, 01023-1020